| Cystic fibrosis | Non-suppurative lung disease | |
| Subjects | 10 | 10 |
| Sex M/F | 2/8 | 7/3 |
| Age yrs | 14.1 (12.8–15.7) | 13.1 (8.6–15.4) |
| Diagnosis | ||
| Cystic fibrosis | 10 | |
| Obliterative bronchiolitis | 3 | |
| Pulmonary arterial hypertension | 4 | |
| Pulmonary venoocclusive disease | 1 | |
| Interstitial lung disease | 1 | |
| Eisenmenger syndrome | 1 | |
| Type of transplant | ||
| Bilateral lung | 9 | 7 |
| Heart–lung | 1 | 3 |
| Indication for bronchoscopy | ||
| Surveillance | 9 | 9 |
| Suspected rejection | 1 | 1 |
| Duration post-transplant months | 12 (2.9–15.5) | 7 (2.3–15) |
| FEV1 % pred at time of bronchoscopy | 75.5 (54.5–96) | 74 (60.5–97) |
| BAL | ||
| No organisms | 6 | 5 |
| URT commensals | 3 | 4 |
| Mycobacterium abscessus | 1 | |
| Streptococcus pneumoniae | 1 | |
| Transbronchial biopsy | ||
| No acute cellular rejection | 10 | 10 |
| A0B0 | 8 | 7 |
| A0BX | 2 | 3 |
| Gastro-oesophageal reflux disease requiring Nissen fundoplication | 9 | 8 |
| BAL lipid laden macrophages >10% | 3 | 4 |
Data are presented as n or median (interquartile range). M: male; F: female; FEV1: forced expiratory volume in 1 s; % pred: % predicted; BAL: bronchoalveolar lavage; URT: upper respiratory tract; A0: no evidence of acute rejection; B0: no airway inflammation/lymphocytic bronchiolitis; BX: insufficient specimen for assessment.